Latest Breaking News On - Mondher mahjoubi - Page 8 : comparemela.com

Innate Pharma SA: Innate Pharma Reports First Quarter 2022 Financial Results and Business Update

First patient dosed in monalizumab Phase 3 lung cancer trial, PACIFIC-9 sponsored by AstraZeneca, which triggered a $50 million milestone payment extending Company cash runway into 2024 Monalizumab

United statesUnited kingdomHenry wheelerInstitut paoli calmettesMondher mahjoubiBristol myers squibbNovo nordiskFrench financial markets authorityCompany annual report on formExchange commissionAmerican association for cancer researchLymphoma study associationEuropean society for medical oncologyEuronext parisChief executive officerInnate pharma

Innate Pharma Reports First Quarter 2022 Financial Results and Business Update

MARSEILLE, France (BUSINESS WIRE) May 10, 2022

United statesUnited kingdomInstitut paoli calmettesMondher mahjoubiBristol myers squibbNovo nordiskFrench financial markets authorityCompany annual report on formExchange commissionAmerican association for cancer researchLymphoma study associationEuropean society for medical oncologyEuronext parisChief executive officerInnate pharmaCompany sponsored phase

Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update

Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHenry wheelerJoyson karakunnelMondher mahjoubiBristol myers squibbNovo nordiskProduct portfolio strategy business developmentExchange commissionFrench financial markets authorityCompany annual report on formEuronext parisChief executive officerExecutive vice presidentChief medical officerProduct portfolio strategy

Innate Pharma SA: Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Tuesday, May 10, 2022 at 2 p.m. CEST

United statesUnited kingdomHenry wheelerJoyson karakunnelMondher mahjoubiBristol myers squibbNovo nordiskProduct portfolio strategy business developmentExchange commissionFrench financial markets authorityCompany annual report on formRegulatory newsEuronext parisChief executive officerExecutive vice presidentChief medical officer

Innate Pharma: First Patient Dosed in Monalizumab Phase 3 Lung Cancer Clinical Trial Triggers $50M Payment From AstraZeneca

Innate Pharma: First Patient Dosed in Monalizumab Phase 3 Lung Cancer Clinical Trial Triggers $50M Payment From AstraZeneca
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Henry wheelerMondher mahjoubiBristol myers squibbSusan galbraithNovo nordiskWorld health organizationFrench financial markets authorityCompany annual report on formExchange commissionLungevity foundationInternational agency for research on cancerEuropean society for medical oncologyWall streetEuronext parisChief executive officerClinical oncologyon april